Annual Current Liabilities
$20.05 M
+$7.80 M+63.76%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual total current liabilities is $20.05 million, with the most recent change of +$7.80 million (+63.76%) on December 31, 2023.
- During the last 3 years, GYRE annual current liabilities has risen by +$9.75 million (+94.71%).
- GYRE annual current liabilities is now at all-time high.
Performance
GYRE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$14.72 M
-$858.00 K-5.51%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly total current liabilities is $14.72 million, with the most recent change of -$858.00 thousand (-5.51%) on September 30, 2024.
- Over the past year, GYRE quarterly current liabilities has dropped by -$5.33 million (-26.59%).
- GYRE quarterly current liabilities is now -26.59% below its all-time high of $20.05 million, reached on December 31, 2023.
Performance
GYRE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GYRE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.8% | -26.6% |
| 3 y3 years | +94.7% | +14.8% |
| 5 y5 years | +94.7% | +14.8% |
GYRE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +94.7% | -26.6% | +14.8% |
| 5 y | 5-year | at high | +94.7% | -26.6% | +14.8% |
| alltime | all time | at high | +94.7% | -26.6% | +14.8% |
Gyre Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $14.72 M(-5.5%) |
| Jun 2024 | - | $15.57 M(-20.1%) |
| Mar 2024 | - | $19.49 M(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $20.05 M(+63.8%) | $20.05 M(+56.3%) |
| Mar 2023 | - | $12.82 M |
| Dec 2022 | $12.24 M(+18.9%) | - |
| Dec 2021 | $10.30 M | - |
FAQ
- What is Gyre Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Gyre Therapeutics?
- What is Gyre Therapeutics annual current liabilities year-on-year change?
- What is Gyre Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly current liabilities year-on-year change?
What is Gyre Therapeutics annual total current liabilities?
The current annual current liabilities of GYRE is $20.05 M
What is the all time high annual current liabilities for Gyre Therapeutics?
Gyre Therapeutics all-time high annual total current liabilities is $20.05 M
What is Gyre Therapeutics annual current liabilities year-on-year change?
Over the past year, GYRE annual total current liabilities has changed by +$7.80 M (+63.76%)
What is Gyre Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of GYRE is $14.72 M
What is the all time high quarterly current liabilities for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly total current liabilities is $20.05 M
What is Gyre Therapeutics quarterly current liabilities year-on-year change?
Over the past year, GYRE quarterly total current liabilities has changed by -$5.33 M (-26.59%)